Introduction
It is generally accepted that the indicence of thyroid disease is subject to geographic variation. Thyrotoxicosis is rare in the African (Blacklock, 1925; de Smet, 1954;  Kihn, 1957) . Trowell (1960) in his 29 year's service in East Africa reported only two cases of thyrotoxicosis. In Southern Rhodesia, Gelfand (1962) reported one case of primary thyrotoxicosis. Patel (1962) reported a series of five cases in Uganda and Wright reported eight cases from Kenya in 1967. There has also been a number of reports from Nigeria. Davey & Ogunlesi (1963) described seven cases in Ibadan. Adesola (1968) reported seven cases in Lagos, Nigeria. The purpose of this study is to review all cases of thyrotoxicosis seen in a large teaching hospital in Nigeria with the aim to determine the characteristics and the problems of this disease as seen in this community. It is hoped that the analysis of the largest series, so far, from Africa will supply sufficiently educative and statistically significant data and illustrate the points of differences and similarities with thyrotoxicosis as seen in other lands.
Material and methods
The University College Hospital in Ibadan is the largest and oldest teaching hospital in Nigeria Since its inception in 1957 it has served practically the whole country until newer teaching hospitals were established less than 10 years ago. Naturally, a vast majority of the patients came from areas nearer the hospital. All patients with any type of thyroid disease seen and treated in the hospital from 1957 to 1970 were reviewed. The hospital records, viz. casenotes, operation and histological records and chemical pathological reports were studied in detail. A thorough prosepctive study of ten patients was carried out over a period of 5 years. Only cases with adequate information in their case-notes and those studied prospectively were included. Thyrotoxic patients who were diagnosed solely clinically and who, on retrospective review, satisfied Wayne's diagnostic index were included. Patients with a clinical diagnosis of thyrotoxicosis which was supported by special thyroid function laboratory tests were also included. Non-Nigerians were not included in this study. Children under the age of 5 years were excluded from this series. The follow-up of some patients was carried out personally. A few defaulting patients were traced to their homes for the purpose of this study. 874 patients, an incidence of 5 3%4. The age of the patients ranged from 8 to 70 years with a peak in the third and fourth decade. There were thirty-six females and ten males giving a ratio of 3 6: 1. Table  1 shows the age and sex distribution, and it also shows that the female predominates in all age groups except at the extremes of life when the numbers were too few to be significant. Clinical features The duration of thyrotoxic symptoms varied from 3 months to about 2 years. There was a history of pre-existing goitre in nineteen patients, the duration of the goitre varying from 4 to 35 years before the onset of toxicity. The symptomatology included loss of weight, increased appetite, excessive sweating, heat intolerance, protruding eyes, diarrhoea, palpitation, nervousness and irritability, tiredness, difficulty in breathing especially on exertion, polyuria, insomnia and amenorrhoea. There were seven severe cases including one neglected patient in very severe drug-resistant thyrotoxicosis who died some days after admission. The signs included the presence of visible and palpable goitre, bilateral exophthalmos, fine to gross tremours of the hands, warm moist hands, tachycardia during sleep, bruit over the gland and auricular fibrillation. Table 2 gives a detailed analysis of the symptoms and signs and the percentage incidence of each feature. There were twenty-seven patients with primary thyrotoxicosis: twenty-five had diffuse goitres and two had no goitres at all (Fig. 1) . Nineteen patients had secondary thyrotoxicosis with pre-existing multinodular goitres (Fig. 2) (Table 2) .
Treatment with results Antithyroid drugs alone were used for treating sixteen patients. Propylthiouracil was exhibited for three and carbimazole for thirteen patients who had primary thyrotoxicosis. One of the latter group was being prepared for thyroidectomy but she failed to return for the operation, probably because she felt better! The immediate effects of the drugs were gratifying in fifteen cases but none of these patients reported for further assessment for more than 8 months. It was thus impossible to assess the longtime effects of the drugs. One of the patients proved uncontrollable and she died of severe thyrotoxicosis.
Three patients were treated with radio-active iodine; two were about 60 years of age and the third, a 35-year-old woman, had had two previous operations for recurrent goitrous thyrotoxicosis. None of them was seen in the follow-up clinics after 9 months.
Subtotal thyroidectomy was performed on fifteen primary and twelve secondary thyrotoxic patients. All except two patients had adequate pre-operative antithyroid drug preparation. The two exceptions escaped correct pre-operative diagnosis and both had a postoperative thyroid crisis. There was no operative mortality. The immediate postoperative results were satisfactory in so far as thyrotoxicosis was concerned. The postoperative follow-up was poor because none of the patients returned after 3 years. Seven patients were traced to their homes in various parts of the country 4-9 years after thyroidectomy. They were all clinically euthyroid.
The patient with thyroid carcinomatosis and thyrotoxicosis was treated with carbimazole and thyroxine, the latter being later replaced with thyroid extract.
She improved tremendously. The ideal treatment for her would have been 131I, but this was not available.
Pathology
The weight of the excised goitrous tissue in twentyseven patients varied considerably. It weighed under 100 g in seven patients; between 100 and 200 g in ten patients and between 200 and 300 g in four patients. The weight was between 400 and 600 g in four patients. In one patient the excised gland weighed 1200 g and in another it weighed 1750 g. The weight of the goitre was not recorded in two patients. The excised thyroid tissue macroscopically showed diffuse enlargement in fifteen patients and was multinodular in ten patients; solitary nodules were recorded in two patients. Relevant information was not available in the others. Microscopically, fifteen patients showed active hyperplastic goitres with features typical of treated thyrotoxicosis. 'Active solitary adenoma' was described in two patients and nodular colloid goitre in eight patients. There was a mixed follicular and papillary carcinoma in one patient and follicular carcinomatosis in another.
Discussion
All the patients in this series are Nigerians. The significant finding is that thyrotoxicosis is a relatively rare disease in Nigeria, an incidence of 5-3%°of patients with thyroid disorders. Reports from many observers in other parts of Africa also indicate that thyrotoxicosis is rare in the African : Wilson et al. (1954) , Davidson (1954) , Bowesman (1960) and Shee & Houston (1963) . Recently, however, Wright (1967) and Nevill & Kunga (1969) indicate that thyrotoxicosis might not be as rare in the African as has been previously reported. Wright (1967) 1963) , Young & Meachim (1964 ), Till (1965 and Kennedy (1970) (Table 3 ). The factors responsible for the low incidence of thyrotoxicosis in the African are not known, thought environmental and racial factors have been suggested by Trotter (1962) and Patel (1963) . Thyrotoxicosis, as a whole, has a peak ageincidence at 21-40 years in this series as shown by Table 1 . When, however, primary is separated from secondary thyrotoxicosis, it becomes evident that the peak age-incidence for primary thyrotoxicosis is 21-30 years and the peak for secondary thyrotoxicosis is the 41-50 decade. The former is in agreement with the finding of Patel in Uganda. It is probably significant that the peak age-incidence in 1000 cases of all types of thyroid diseases seen in this hospital, in which 87% constitutes simple goitres, is 31-40 years (Olurin et al., 1971) . Primary thyrotoxicosis thus appears to occur a decade earlier in this series than in Britain, according to Young & Meachim (1964) . Thyrotoxicosis is commoner in the female than in the male but the male incidence appears to be higher in this series than in the European and American patients.
The symptoms and signs of thyrotoxicosis in many of these patients are so marked that there is no difficulty in the diagnosis. This is particularly so in primary thyrotoxicosis because patients do not, generally, seek medical advice in the early phase of illness in this community. In some patients with secondary thyrotoxicosis the clinical features are not always unequivocal. The picture is further complicated by the finding, in these patients, that many multinodular simple goitres in euthyroid patients take up iodine avidly. The bigger the goitre the higher the iodine uptake. Indeed they behave very much like endemic goitres (Stanbury, 1958) . It is probably relevant to point out that the majority of patients with multinodular goitres and secondary thyrotoxicosisis live in areas where goitres are locally known to be endemic.
Thus, in mild secondary thyrotoxicosis occurring in multinodular goitres both the clinical assessment and radio-active uptake studies may not be of great help in diagnosis. The serum protein-bound iodine estimations, however, have provided values which give a more sensitive index of thyroid function irrespective of size in these mild cases. It would appea. that a number of patients with secondary thyrotoxicosis are indeed cases of Basedow thyrotoxicosis. During the last 5-10 years there has been an improvement in the standard of living in many rural areas: the diet is better balanced, pipe-borne water is available in many areas, travelling is easier and illiteracy is gradually diminishing. It is therefore plausible to argue that the iodine content of food and water is gradually increasing in areas which had had a low iodine supply. More iodine is being made available to multinodular goitres, which show -avid iodine uptakes under laboratory conditions. The large proportion of secondary thyrotoxicosis in this series is thus explained. On this basis, it is to be expected that the number of secondary thyrotoxic patients will increase in future if improvement in the standard of living continues in areas where simple multinodular goitre is common. In favour of this phenomenon is the fact that endemic thyrotoxicosis has been observed by Stewart and his co-workers (1971) following iodination of bread in Northern Tasmania which is known to be a goitrous area. The association of thyrotoxicosis and carcinoma of the thyroid in two cases (7%°) in this series is interesting. Although it was once thought that thyrotoxicosis was a sort of insurance against carcinoma of the thyroid (Mean, 1948) yet in recent years there has been a number of reports on the occurrence of both diseases co-existing, as shown in Table 4 . Thyroidectomy was performed in twentyseven offorty-sixpatients and only theexcised goitrous tissues of these patients were subjected to histopathological examination. The rest of the patients had either antithyroid drugs or 1311 therapy. It would not be known whether any of these contained carcinoma. It is thus possible that carcinoma of the thyroid occurring in thyrotoxic patients treated medically is being missed, and therefore the incidence of carcinoma in the thyrotoxic gland may be greater than has been found.
The management of thyrotoxicosis in this hospital does not differ significantly from that in practice elsewhere (Riddell, 1965 On the other hand, it is too expensive, difficult and time-consuming to carry out regular visits, however infrequent, to the homes of these patients.
Conclusion
Thyrotoxicosis is a rarer disease in Nigeria than in Europe and North America. There is a high incidence of secondary thyrotoxicosis in the multinodular goitre in this series, probably as a result of gradual improvement in the socio-economic situation of the patients, especially those from rural areas where goitre is known to be endemic. Thyrotoxicosis is four times as common in the female as in the male. It 
